AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/542
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSilbert, Brendan-
dc.contributor.authorEvered, Lisbeth-
dc.contributor.authorScott, David A-
dc.contributor.authorMcCutcheon, Craig-
dc.contributor.authorJamrozik, Konrad-
dc.date2008-
dc.date.accessioned2018-05-03T06:02:51Z-
dc.date.available2018-05-03T06:02:51Z-
dc.date.issued2008-
dc.identifier.citationDementia and geriatric cognitive disorders 2008; 25(4): 309-16-
dc.identifier.urihttp://hdl.handle.net/11055/542-
dc.description.abstractRaised concentrations of plasma homocysteine and C-reactive protein (CRP) are associated with vascular disease and have also been implicated as independent risk factors for cognitive impairment in population studies. To investigate the association of plasma homocysteine and CRP with cognition in patients scheduled for coronary artery bypass graft (CABG) surgery. Cognition was assessed in 264 patients using a standard battery of neuropsychological tests. Patients were classified as having preexisting cognitive impairment (PreCI) by reference to a healthy control group or postoperative cognitive dysfunction (POCD) by reference to baseline test scores. PreCI was present in 37.3% of patients, and POCD was present in 18.3, 12.1 and 13.6% of patients at 1 week, 3 months and 12 months postoperatively. On multivariate analysis neither homocysteine nor CRP were independently associated with cognition at any testing time but were strongly associated with age and left ventricular function. PreCI and POCD are present in a substantial proportion of patients undergoing CABG surgery but there is no independent association with either baseline homocysteine or CRP levels. It is possible that cognitive impairment may result from the vascular disease rather than a direct association with either homocysteine or CRP.-
dc.language.isoeng-
dc.subject.meshAged-
dc.subject.meshBiomarkers-
dc.subject.meshC-Reactive Protein-
dc.subject.meshCognition Disorders-
dc.subject.meshCoronary Artery Bypass-
dc.subject.meshCoronary Artery Disease-
dc.subject.meshHomocysteine-
dc.subject.meshMiddle Aged-
dc.subject.meshMultivariate Analysis-
dc.subject.meshPrevalence-
dc.subject.meshRisk Factors-
dc.titleHomocysteine and C-reactive protein are not markers of cognitive impairment in patients with major cardiovascular disease.-
dc.typeJournal Article-
dc.typeResearch Support, Non-U.S. Gov't-
dc.identifier.journaltitleDementia and geriatric cognitive disorders-
dc.identifier.doi10.1159/000119105-
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/18311078-
dc.identifier.pubmedid18311078-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairetypeResearch Support, Non-U.S. Gov't-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.cerifentitytypePublications-
Appears in Collections:Scholarly and Clinical
Show simple item record

Page view(s)

168
checked on May 3, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.